| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $75.0M | — | +13.4% |
| Cost of Revenue | $15.3M | — | +13.6% |
| Gross Profit | $59.7M | — | +13.3% |
| R&D Expense | $19.0M | — | +19.6% |
| SG&A Expense | $7.7M | — | -9.2% |
| Operating Income | $13.0M | — | +48.1% |
| Interest Expense | $1.9M | — | +533.3% |
| Income Tax | $2.2M | — | +134.4% |
| Net Income | $12.0M | — | +26.1% |
| EPS (Basic) | $0.17 | — | +30.8% |
| EPS (Diluted) | $0.17 | — | +30.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $57.9M | -18.6% | -76.3% |
| Short-term Investments | $311.9M | +1.7% | +178.5% |
| Accounts Receivable | $69.0M | +11.2% | +5.5% |
| Inventory | $20.2M | +11.9% | -1.8% |
| Current Assets | $479.5M | +0.8% | +4.7% |
| Total Assets | $634.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.2M | — | -87.0% |
| Capital Expenditures | $2.9M | — | -35.0% |
| Investing Cash Flow | -$8.7M | — | +75.0% |
| Financing Cash Flow | -$6.8M | — | -104.1% |
| Free Cash Flow | -$689K | — | -105.4% |
| +4.7% |
| Current Liabilities | $129.1M | -3.4% | +14.0% |
| Long-term Debt | $219.2M | +0.2% | +0.7% |
| Total Liabilities | $413.6M | -1.1% | +0.8% |
| Stockholders' Equity | $220.8M | +4.4% | +12.7% |